detected higher levels of tRF-17-18VBY9M expression in the serum and tumor tissues of gastric cancer patients (5), while in NSCLC, a reduction in the levels of i-tRF-AspGTC and tRF-1-SerCGA has been reported in serum exosomes (6). This evidence concerns the gene TERF1 and neoplasm.